The methods and compositions provided herein relate generally to IL-10specific antibodies and uses thereof. More specifically, compositions ofhumanized IL-10 specific antibodies and methods to use such antibodies inmodulating the biological activity of IL-10, particularly in autoimmunedisorders and pathogen-mediated immunopathology.